The activity of serial concentrations of different antimicrobial agents on the multiplication of Legionella pneumophila within human monocyte-derived macrophages was studied. The results led to the definition of a minimal extracellular concentration inhibiting intracellular multiplication (MIEC). According to the MIECs, the antimicrobial agents tested were classified in three groups: (i) very active (MIEC < 0.06 ,ug/ml), such as erythromycin, rifampin, and pefloxacin; (ii) active (1 ,ug/ml 2 MIEC 2 0.1 ,ug/ml), such as sulfamethoxazoletrimethoprim or doxycycline; and (fii) ineffective, such as cefoxitin, which was not active within macrophages at as high as 64 ,ug/ml despite a low MIC (0.2 ,Lg/ml) on bacterial charcoal-yeast extract agar. The activity of netilmicin was difficult to assess because of its effect on extraceliular legionellae. Combinations of erythromycin with rifampin and pefloxacin with erythromycin, rifampin, doxycycline, or netilmicin showed an additive effect and no antagonism. These results obtained in a cellular model are in
Legionella pneumophila, the agent of Legionnaires disease, is a facultative intracellular bacterium which multiplies within phagocytic cells (13) . Erythromycin alone or in combination with rifampin is the currently accepted treatment of Legionnaires disease, though failures or delayed activity are observed, especially in immunocompromised patients (2, 18, 21) . Thus, the activity of other antimicrobial agents has to be tested. However, the assessment of in vitro antibiotic activity by conventional means is misleading because of (i) partial inhibition of some antibiotics by a component(s) of the media used for Legionella growth (3, 6, 16) and (ii) the discrepancy between in vivo inefficacy and in vitro low MICs of some antibiotics, especially 3-lactams, caused by a low intracellular penetration at the site where Legionella sp. multiplies.
To overcome these obstacles, we used a cell model to assess the activity of antibiotics against Legionella sp. multiplying within macrophages. The effect of decreasing concentrations of the anti-infectious agents erythromycin, rifampin, doxycycline, netilmicin, sulfamethoxazole-trimethoprim, pefloxacin, and cefoxitin led to the definition, for each of them, of a minimal extracellular concentration inhibiting the intracellular multiplication (MIEC) of L. pneumophila. Moreover, our results sustain the use of antibiotic combinations and the potential interest of new quinolones such as pefloxacin in the treatment of Legionnaires disease.
MATERIALS AND METHODS Bacteria. L. pneumophila serogroup 1, strain Paris/CB 81-13, was used in all experiments. This strain was isolated from the lung of a patient who died from Legionnaires disease, and it was plated on bacterial charcoal-yeast extract (BCYE) agar only twice before use. Susceptibility of this strain to antimicrobial agents was compared with the sus-* Corresponding author. ceptibility of eight other L. pneumophila serogroup 1 strains isolated from patients and of the L. pneumophila serogroup 1 reference strain ATCC 33152. In vitro antibiotic susceptibility tests were performed by agar dilution with a Steers replicator (3). The medium was BCYE agar with appropriate concentrations of the agents. For the inoculum, a 48-h culture was taken from BCYE agar, suspended in distilled water, and diluted to 1 x 108 to 6 x 108 CFU/ml. Each inoculum spot contained 105 to 106 CFU. Sera. Pooled normal human serum was collected from five healthy donors. Immune serum was obtained from a nonimmunocompromised patient with culture-proven Legionnaires disease; the antibody titer to L. pneumophila serogroup 1 was 1:512 as determined by an immunofluorescence test.
Monocyte-derived macrophages. Human monocytederived macrophages were obtained as described previously (25) from the peripheral blood of a healthy donor who was seronegative (<1:16) for L. pneumophila serogroup 1. Briefly, 15 ml of venous blood mixed with 5 ml of 3% gelatin (Plasmagel; Roger Bellon, Neuilly, France) and 50 ,g of heparin per ml was sedimented at 37°C for 45 min. The leukocyte-rich plasma (2 ml) was poured into Leighton tubes. Between 5 and 12 tubes were used in each experiment. After sedimentation for 3 h at 37°C, the plasma containing nonadherent cells was removed, and adherent cells were incubated with antimicrobial agent-free TC 199 medium (Hanks base) containing 10% normal serum and 50 ,ug of heparin per ml. This nutrient medium without heparin was changed on days 1 and 3, and tubes were incubated with 5% CO2. On day 7, a homogeneous monolayer of wellspread macrophages was obtained.
Antimicrobial agents. The following injectable forms of antimicrobial agents were used: erythromycin lactobionate (Abbott Laboratories, North Chicago, Ill.), rifampin formaldehyde sulfoxylate (Lepetit, Milan, Italy), doxycycline (Pf- 2); thereafter, intracellular bacteria were counted after disruption of macrophages by introduction of 2 ml of distilled water over 30 min and by mechanical shaking. These procedures did not alter the viability of bacteria. In other tubes, the supernatant containing noningested bacteria was removed, and the adhering bacteria were washed out with phosphate-buffered saline. TC 199 medium (2 ml) with 10% normal human serum and various concentrations of antimicrobial agents, alone or in combination, was then added; the total volume was 2 ml per tube. In each experiment, a control tube without agent was included. In an earlier study, we showed that, at 60 min, bacteria were readily ingested and that after washings with phosphate-buffered saline, no cell-bound legionellae were demonstrable morphologically by direct fluorescence assay (24) .
Extra-and intracellular bacteria were enumerated after incubation at 37°C for 24 Thus, values greater than 100% indicated absence of inhibitory effect of the antimicrobial agents and values lower than 100% indicated an inhibitory effect; however, only values lower than or equal to 10% were considered inhibitory (i.e., the number of recovered bacteria with antimicrobial agents 24 h after inoculation was 10-fold less than that without agents). The lowest concentration of agent which had an inhibitory effect on intracellular L. pneumophila multiplication was then referred to as the MIEC.
Withdrawal of antimicrobial agents. In some experiments, erythromycin or pefloxacin was withdrawn by repeated washings after 24 h of contact with L. pneumophila-infected macrophages. Fresh nutrient medium (TC 199 + 10% normal serum) without antimicrobial agents was added at 24 h. Infected macrophages were then incubated further for various lengths of time, and counts of intracellular and extracellular bacteria were determined at designated intervals.
Combinations of antimicrobial agents. The antimicrobial agents were tested on infected macrophages by the checkerboard method (15) with concentrations lower than the MIECs. The number of points tested for each combination was between 7 and 22.
Statistical analysis. A one-way analysis of variance for unequal group sizes was applied to test for significance, by using a significance level of P < 0.05.
RESULTS
MICs of antimicrobial agents against L. pneumophila. The MICs of antimicrobial agents for L. pneumophila Paris CB 81-13 were found to be within the range of the MICs for the reference strain ATCC 33152 and the eight patient strains ( Table 1 ). The MIC of sulfamethoxazole-trimethoprim was too variable, because of the presence ofp-aminobenzoic acid in the BCYE agar, which hampers the assessment of sulfamethoxazole (3). The MIC of trimethoprim was 0.4 ,ug/ml for the strain of L. pneumophila we used and within the range of 0.1 to 2 ,ug/ml for other strains.
Controls. (i) Intracellular multiplication of L. pneumophila without antimicrobial agents. The ratio of total bacteria at 24 h without antimicrobial agent to intracellular bacteria at 60 min was equal to 49 ± 36 (n = 20). Thus, the spontaneous intracellular multiplication of L. pneumophila within macrophages was between 1 and 2 log1o.
(ii) Controls without macrophages. No change of L. pneumophila counts was observed in controls without macrophages and without antimicrobial agents over a 24-h period by using the culture medium TC 199 with 10% normal serum (data not shown). With the exception of netilmicin ( (ii) Rifampin. An inhibitory effect on the intracellular multiplication of L. pneumophila was noted only with rifampin concentrations of 0.01 and 0.005 jig/ml (Table 3) .
Similar analysis as for erythromycin showed that 0.005 ,ug/ml was the MIEC for L. pneumophila.
(iii) Doxycycline, sulfamethoxazole-trimethoprim, and pefloxacin. For doxycycline, sulfamethoxazole-trimethoprim, and pefloxacin, the MIECs for L. pneumophila were 0.8, 0.5/0.1, and 0.0625 jig/ml, respectively ( Table 4) . As for erythromycin and rifampin, concentrations could be classified into two groups. Similar statistical analysis showed no significant differences between values of the ratio within each group (P > 0.05), but a significant difference between individual values of group 1 and group 2 (P < 0.001 for doxycycline and pefloxacin, P < 0.01 for sulfamethoxazoletrimethoprim) was observed.
(iv) Netilmicin. An identical analysis could not be performed for netilmicin, since controls without macrophages showed a high reduction of L. pneumophila count with netilmicin concentrations equal to or higher than 0.25 ,ug/ml. With macrophages, the reduction of the intracellular multiplication was observed with concentrations higher than 0.5 ,u.g/ml and to a lesser degree with 0.5 ,g/ml (Table 2) . Thus, the exact reduction of intracellular multiplication could not be demonstrated, since the reduction observed with macro- (1 and 2) ; between any individual value of group 1 compared with group 2; P < 0.001 for doxycycline and pefloxacin, and P < 0.01 for sulfamethoxazole-trimethoprim.
c For each antimicrobial agent, P is not significant for any individual value. phages could be caused by the effect of netilmicin on extracellular bacteria being released from disrupted macrophages after intracellular multiplication.
(v) Cefoxitin. Cefoxitin had no inhibitory effect on the intracellular multiplication of L. pneumophila even at a concentration as high as 64 ,ug/ml (Table 5) , although a slight but nonsignificant reduction of the total number of bacteria at 24 h was observed with a concentration of 64 ,ug/ml.
Effect of combinations of anti-infectious drugs. Controls without macrophages with the same concentrations of two antimicrobial agents as used with macrophages showed neither reduction nor multiplication of L. pneumophila counts at 24 h. The combination of erythromycin and rifampin yielded the lowest fractional inhibitory concentration index (15), 0.6, of the tested combinations (Fig. 1) . Pefloxacin combined with erythromycin, rifampin, doxycycline, or netilmicin was also tested. The fractional inhibitory concentration index was 1.5 for pefloxacin and rifampin and MIEC were used for each antimicrobial agent: 5 x 10-2 jig/ml for erythromycin and 5 x iO-,ug/ml for rifampin. Results are expressed by the inhibition ratio given in Materials and Methods. Ratios of -10% (0) were considered inhibitory; ratios of >10% (0) were considered noninhibitory. For every combination, the number in parentheses indicates the value of the fractional inhibitory concentration index; values between 0.5 and 1.5 reflect an additive effect.
1 for other combinations. Thus, an additive effect was observed with all tested combinations.
Effect of withdrawal of erythromycin or pefloxacin at 24 h. In these experiments, the number of total bacteria at later times was compared with the number of intracellular bacteria at 60 min. Erythromycin or pefloxacin was used for the first 24 h at 1 ,ug/ml. The remaining intracellular bacteria at 24 h multiplied quickly after withdrawal of erythromycin, leading to the destruction of the macrophage monolayer (Table 6 ). However, withdrawal of pefloxacin was not followed by multiplication of intracellular L. pneumophila until hour 96; after this time only, disruption of the macrophage monolayer by the intracellular growth of bacteria was observed.
DISCUSSION
The macrophage Legionella model used in this study leads to the determination of the MIECs for L. pneumophila. The MIECs are probably more relevant than the conventional MICs in predicting the efficacy of antimicrobial agents against Legionnaires disease. This fact is well illustrated by the discrepancy between the conventional MIC and the MIEC of cefoxitin as demonstrated in the macrophage model. Cefoxitin, which among the cephalosporins has the lowest MIC (23) and is resistant to the P-lactamase of L. pneumophila (11), had no bacteriostatic effect on intracellu-0(1.0) lar L. pneumophila even at a concentration as high as 64 ,ug/ml. Similar results have been obtained with peritoneal macrophages of guinea pigs (26) . This correlates with the inefficacy of cephalosporins and other ,-lactams in experimental infection (4, 5, 19) and in the therapy of Legionnaires disease (4, 17) .
We confirmed that erythromycin and rifampin, which have a well documented activity in vivo against L. pneumophila (9, 17) and in experimental infection of guinea pigs (5, 10, 12) , do inhibit the intracellular multiplication of L. pneumophila at low concentrations. These MIECs were 10-fold lower than the MICs as determined on BCYE agar. Horwitz and Silverstein (14) , using freshly isolated human monocytes, found that the intracellular multiplication of L. pneumophila was inhibited by 1.25 p,g of erythromycin per ml and 0.01 ,ug of rifampin per ml; these concentrations were higher than the MIECs we found.
Doxycycline and sulfamethoxazole-trimethoprim also inhibited the intracellular multiplication of L. pneumophila at low concentrations (0.8 and 0.5 to 0.1 ,Lg/ml, respectively). However, the MIEC of doxycycline (0.8 ,ug/ml) was close to its MIC (1 ,ug/ml) and higher than the MIEC of erythromycin (0.05 ,ug/ml) and of rifampin (0.005 ,ug/ml), as previously noted by using peritoneal macrophages of guinea pigs (26) ; this could be related to the partial and low efficacy of tetracyclines in human Legionnaires disease (9, 17) . Trimethoprim alone (4) and sulfamethoxazole-trimethoprim (19, 20) have been shown to be active in experimental infection of guinea pigs. However, the clinical efficacy of sulfamethoxazole-trimethoprim against Legionnaires disease is still to be confirmed (17) . The determination of the MICs of sulfamethoxazole-trimethoprim and sulfarnethoxazole against L. pneumophila remains an unresolved question with large variations (3, 5, 20, 23) caused by the nature and compounds of the culture medium (5) . This emphasizes the interest of the MIEC determination in a cell culture model.
Pefloxacin, a new quinolone suitable for treatment of systemic infections, exhibited a high activity against intracellular L. pneumophila. This compound is also active against experimental Legionella infection of guinea pig (1). The persistence of its effect on intracellular Legionella sp. after its withdrawal may be explained either by the persistence of the drug within the cells or by a particularly potent effect on intracellular bacteria which does not allow them to multiply before 3 days. This postantibiotic effect of pefloxacin has been observed also in the experimental infection of guinea pigs (1) . Erythromycin, on the other hand, did not exhibit this persistent antibacterial effect either in the macrophage model or within human monocytes (14) ; nor was it observed in experimental infection of guinea pigs (1).
Other new quinolones such as ciprofloxacin (7) and ofloxacin (22) also exhibit a high activity against intracellular L. pneumophila at concentrations close to those effective for pefloxacin. Ofloxacin and ciprofloxacin are also active in experimental infection of guinea pigs (8, 22) . These results strongly suggest that these new quinolones may be used (5) , is hampered by the theoretical risk of emergence of resistant mutants (3) . These facts sustain the use of combinations of erythromycin and rifampin in critically ill patients. Other combinations, such as new quinolones and rifampin, may also be assessed in such cases.
